Has anyone heard about a new contraceptive patch that a Johnson & Johnson company has applied for FDA approval on?  My guess is that its convenience will probably make it very popular.  

JOHNSON & JOHNSON COMPANY FILES CONTRACEPTIVE PATCH WITH FDA
The RW Johnson Pharmaceutical Research Institute (PRI), a Johnson & Johnson company, said on Wednesday that it has submitted a new drug application for the Ortho Evra (norelgestromin/ethinyl estradiol)
transdermal contraceptive patch to the US Food and Drug Administration (FDA). 
http://womenshealth.medscape.com/31821.rhtml?srcmp=wh-122900

The report says this new patch provides 7-day continuous levels of estrogen and progestin.  Similar, maybe to the combination oral contraceptives we advise breastfeeding mothers to avoid because of impact on milk supply?
  
Cathy Carothers, BLA, IBCLC

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html